Pfizer (PFE) SVP Damico has 655 shares withheld for RSU tax

Rhea-AI Filing Summary

Pfizer Inc. senior vice president and controller Jennifer B. Damico reported a tax-related share disposition. On February 27, 2026, 655 shares of Pfizer common stock at $27.65 per share were withheld to cover tax obligations upon the vesting of restricted stock units, leaving her with 12,041 directly owned shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAMICO JENNIFER B.

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NY 10001-2192

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Controller

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		F		655(1)	D	$27.65	12,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

	/s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Pfizer (PFE) report for Jennifer B. Damico?

Pfizer reported a tax-related share disposition by SVP & Controller Jennifer B. Damico. On February 27, 2026, 655 shares were withheld to satisfy tax obligations upon vesting of restricted stock units, rather than an open-market sale.

How many Pfizer (PFE) shares were involved in Jennifer B. Damico’s Form 4?

The Form 4 shows 655 shares of Pfizer common stock were withheld at $27.65 per share. This withholding covered tax obligations triggered by the vesting of restricted stock units and associated dividend equivalents.

Did Jennifer B. Damico sell Pfizer (PFE) shares on the open market?

No, the Form 4 indicates a tax-withholding disposition, not an open-market sale. Shares were withheld by the company to satisfy tax liabilities when restricted stock units and related dividend equivalents vested.

How many Pfizer (PFE) shares does Jennifer B. Damico own after this transaction?

After the tax-withholding disposition, Jennifer B. Damico directly owns 12,041 Pfizer common shares. This figure reflects her holdings following the 655 shares withheld to cover tax obligations on vested restricted stock units.

What does transaction code "F" mean in the Pfizer (PFE) Form 4?

Transaction code “F” represents payment of an exercise price or tax liability by delivering securities. In this case, 655 Pfizer shares were withheld to satisfy tax obligations arising from vesting restricted stock units, rather than being sold on the market.